Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             269 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A Bayesian approach to the design of phase II clinical trials Sylvester, Richard J.
1991
12 5 p. 655-
1 p.
artikel
2 Abstracts 1991
12 5 p. 670-
1 p.
artikel
3 A clinical applications generator optimizing patient recruitment and data integrity within automated investigator groups Van Bruwaene, B.
1991
12 5 p. 681-682
2 p.
artikel
4 A clinical research management system De Rosa, M.
1991
12 5 p. 693-
1 p.
artikel
5 A clinical trials database as a research tool in medical care Morris, Robert D.
1991
12 5 p. 620-
1 p.
artikel
6 A comparative study of non-randomized and randomized controls Ward, L.C.
1991
12 5 p. 661-
1 p.
artikel
7 A comparison of computer and human coronary angiographic end-point measures Mack, Wendy
1991
12 5 p. 716-
1 p.
artikel
8 A comparison of odds ratio and relative risk models for binary data le Cessle, S.
1991
12 5 p. 619-
1 p.
artikel
9 A comparison of quality-of-life measures in a randomized trial Glasziou, P.P.
1991
12 5 p. 653-
1 p.
artikel
10 A computer generated patient tracking and accrual mechanism for clinical trials Stark, Ryan M.
1991
12 5 p. 717-
1 p.
artikel
11 A computer program for the design and the analysis of phase II cancer clinical trials with the triangular test Bellissant, Eric
1991
12 5 p. 710-
1 p.
artikel
12 A conditional probability sequential stopping rule for clinical trials Snapinn, Steven M.
1991
12 5 p. 637-
1 p.
artikel
13 A cost-benefit analysis: Certification of multiple visual acuity examiners per center in multicenter clinical trials McCaffrey, Lee
1991
12 5 p. 714-
1 p.
artikel
14 A criterion for the adequacy of a simple design when a complex model will be used for analysis Aickin, Mikel
1991
12 5 p. 560-565
6 p.
artikel
15 A database design for automated data management of multicenter clinical trials Beller, Elaine M.
1991
12 5 p. 620-
1 p.
artikel
16 Advantages and disadvantages of treatment preference designs for clinical trials Holbrook, Janet T.
1991
12 5 p. 622-
1 p.
artikel
17 A flaw in the generalized maximum likelihood estimate with a suggested repair Chappell, Rick
1991
12 5 p. 703-
1 p.
artikel
18 A funding mechanism for clinical trials: The clinical trial planning grant Kurinij, Natalie
1991
12 5 p. 683-
1 p.
artikel
19 A general measure of correlation for logistic model El Hasnaoul, A.
1991
12 5 p. 688-689
2 p.
artikel
20 Agreement assessment in multicenter clinical trials Cesana, Bruno
1991
12 5 p. 701-702
2 p.
artikel
21 A latent class model that allows triple-label immunophenotypic analysis of cells based upon double-label measurements van Putten, W.L.J.
1991
12 5 p. 690-
1 p.
artikel
22 Alert systems for post-marketing surveillance of adverse drug events— Methods and problems Praus, M.
1991
12 5 p. 659-
1 p.
artikel
23 Alternative methods for describing treatment benefits including quality-of-life considerations Gelber, Richard
1991
12 5 p. 638-
1 p.
artikel
24 A model-based approach to estimate the survival distributions of treatment groups in a clinical trial using longitudinal data Dunlop, Dorothy D.
1991
12 5 p. 667-
1 p.
artikel
25 Analysis of medical costs as a secondary end-point in a clinical trial Smith, L.Richard
1991
12 5 p. 638-
1 p.
artikel
26 Analysis of nonfatal outcomes in clinical trials when mortality is present McMahon, Robert
1991
12 5 p. 625-
1 p.
artikel
27 Analysis of outcome data from a randomized clinical trial with multiple subunits per unit of randomization Lin, Lillian S.
1991
12 5 p. 685-
1 p.
artikel
28 Analysis of prospective epidemiological studies involving an intermediate event: Applications of cox's survival model Galai, Noya
1991
12 5 p. 627-
1 p.
artikel
29 Analysis of recurrent events in superficial bladder cancer Barton, Bruce A.
1991
12 5 p. 688-
1 p.
artikel
30 Analysis of repeated measures in clinical trials using summary statistics Frison, Lars
1991
12 5 p. 632-
1 p.
artikel
31 Analysis of the circadian blood pressure curve in normal men Thijs, Lutgarde
1991
12 5 p. 646-647
2 p.
artikel
32 Analysis strategies for randomized studies with continuous outcomes: Post-intervention measurements versus change scores Black, Dennis M.
1991
12 5 p. 671-
1 p.
artikel
33 Analyzing edit queries to identify problems in data collection, edits, and management Hoover, Brett A.
1991
12 5 p. 649-
1 p.
artikel
34 An analysis of methods of communication in clinical trials Sheridan, Lenore
1991
12 5 p. 711-
1 p.
artikel
35 An analysis strategy for multi-dose combination drug clinical trials Philips, James
1991
12 5 p. 661-
1 p.
artikel
36 A new clinical trials design for aids research: The “measured-choice” design Rochon, James
1991
12 5 p. 621-
1 p.
artikel
37 A new strategy of method comparison in clinical chemistry with a improved sequential estimation procedure and diagnostic validation Banik, Norbert
1991
12 5 p. 705-706
2 p.
artikel
38 An illustration of survival analysis: A study of intensive care unit patients Estarelles, R.
1991
12 5 p. 673-
1 p.
artikel
39 A parallel dose-titration design to determine dose range in patients with stable chronic disease Pun, Edward F.C.
1991
12 5 p. 622-623
2 p.
artikel
40 A phase II design for therapies which may be ineffective Garnsey, L.
1991
12 5 p. 655-656
2 p.
artikel
41 Application of random effects regression to longitudinal psychiatric data Ragin, Ann Barnett
1991
12 5 p. 673-
1 p.
artikel
42 Application of regression tree method as a tool to analyze a clinical trial Ulm, K.
1991
12 5 p. 684-
1 p.
artikel
43 Applying the ISO/OSI model to distributed data entry systems Balley, Lance R.
1991
12 5 p. 677-
1 p.
artikel
44 A simulation study of estimators for rates of change in longitudinal studies with attrition Wang, F.
1991
12 5 p. 671-
1 p.
artikel
45 A simulation study on the behavior of variable-selecting algorithms in linear regression models Kron, Martina
1991
12 5 p. 674-
1 p.
artikel
46 A study of patient accrual patterns in 23 VA multicenter clinical trials Henderson, William G.
1991
12 5 p. 658-
1 p.
artikel
47 A test for a difference in a continuous outcome in a drug trial of fixed length when there are dropouts Brown, Morton B.
1991
12 5 p. 671-
1 p.
artikel
48 Bayesian analysis of neutron therapy trial Abrams, Keith
1991
12 5 p. 666-667
2 p.
artikel
49 Block designs with neighbor correlations Derzko, Gerard
1991
12 5 p. 660-
1 p.
artikel
50 BOB (Baseline or Better)-time: A new end-point to analyze marker data in aids therapies Beltangady, Mohan
1991
12 5 p. 702-703
2 p.
artikel
51 Cancer prevention trials using micronutrients: Design issues Patterson, Blossom H.
1991
12 5 p. 695-
1 p.
artikel
52 Characteristics of pharmacokinetic modelling in a phase I clinical trial of radiolabeled monoclonal antibody Liu, Tiepu
1991
12 5 p. 654-655
2 p.
artikel
53 Choice of a radiological end-point in the evaluation of the effect of drugs on atherosclerotic lesions of restenosis after angioplasty Lievre, M.
1991
12 5 p. 623-624
2 p.
artikel
54 Clinical trials of investigational antiepileptic drugs: Monotherapy designs Pledger, Gordon W.
1991
12 5 p. 622-
1 p.
artikel
55 Closed testing procedures for multiple end-point analysis Hothorn, L.
1991
12 5 p. 684-
1 p.
artikel
56 Comparative evaluation of the quality of life: Use of spitzer index in ovarian cancer trials Beltangady, Mohan
1991
12 5 p. 702-
1 p.
artikel
57 Comparative study of multiple testing procedures in phase II clinical trials Seguret, F.
1991
12 5 p. 718-
1 p.
artikel
58 Comparing different epidemiological studies: How to summarize risk associations in a consistent form Thompson, S.G.
1991
12 5 p. 656-
1 p.
artikel
59 Comparison of clinical trials regulatory requirements and practice between European community and United States Herson, Jay
1991
12 5 p. 658-
1 p.
artikel
60 Comparison of definitions of nearest neighbor distances in the case of censored data—A simulation study Gefeller, Olaf
1991
12 5 p. 703-704
2 p.
artikel
61 Comparison of methods for follow-up by mail Mickel, Mary
1991
12 5 p. 680-
1 p.
artikel
62 Comparison of quality of life in the program on the surgical control of hyperlipidemias (POSCH) by a standard instrument and a study specific questionnaire Stuenkel, Meredith
1991
12 5 p. 654-
1 p.
artikel
63 Competence, control, confirmation and refutation Senn, Stephen
1991
12 5 p. 643-
1 p.
artikel
64 Compliance in the physician's health study Glynn, Robert J.
1991
12 5 p. 672-
1 p.
artikel
65 Computer-assisted radiographic digitization in the assessment of total HIP implants Gupta, Sunil Kumar
1991
12 5 p. 664-
1 p.
artikel
66 Computerized management of treatment assignments Van Natta, Mark
1991
12 5 p. 692-
1 p.
artikel
67 Conducting clinical study of GCP standards in the Soviet union-case analysis Vuorinen, J.
1991
12 5 p. 683-
1 p.
artikel
68 Considerations in assessing risk factors for main ocular outcomes in the early treatment diabetic retinopathy study Barton, Franca
1991
12 5 p. 704-
1 p.
artikel
69 Coordinating center (COC) management of pre-randomization eligibility in the diabetes control and complications trial (DCCT) Brenneman, Anne T.
1991
12 5 p. 692-
1 p.
artikel
70 Corneal transplant follow-up study (CTFS) Vall, A.
1991
12 5 p. 698-
1 p.
artikel
71 Cumulative incidence functions should replace integrated cause-specific hazard functions to describe probabilities of competing events over time Gelber, Richard D.
1991
12 5 p. 624-625
2 p.
artikel
72 Data correction strategies for multicenter clinical trials employing distributed data entry systems Kuntz, Timothy E.
1991
12 5 p. 644-645
2 p.
artikel
73 Data entry training for a small clinical trial Corley, Scott D.
1991
12 5 p. 706-
1 p.
artikel
74 Datafax evaluated Taylor, D.Wayne
1991
12 5 p. 644-
1 p.
artikel
75 Data management concepts at the epidemiology data center Swanson, Polly
1991
12 5 p. 716-717
2 p.
artikel
76 Data management, design and implementation for the global utilization of streptokinase and t-PA for occluded coronary arteries study Muhlbaler, Lawrence H.
1991
12 5 p. 629-630
2 p.
artikel
77 Data management in a multicenter study when participating sites are independently conducting different interventions Miller, J.P.
1991
12 5 p. 628-
1 p.
artikel
78 Data tracking and recording techniques in a multicenter clinical trial Cauch, Karen
1991
12 5 p. 691-
1 p.
artikel
79 Design and analysis considerations in prophylactic studies in recurrent vaginal candidiasis Ying Wang,
1991
12 5 p. 699-
1 p.
artikel
80 Design and implementation of a new prospective randomized clinical trial using informations of subset analysis data from previous trials Junichi Sakamoto,
1991
12 5 p. 697-
1 p.
artikel
81 Design issues when a second drug confounds effects of the primary treatment West, M.Stewart
1991
12 5 p. 695-
1 p.
artikel
82 Detecting data errors with a statistical screens Ledingham, Robert
1991
12 5 p. 706-707
2 p.
artikel
83 Determination of sample size taking account of certain prior information Masashi Goto,
1991
12 5 p. 694-695
2 p.
artikel
84 Developing a quality control (QC) program for bone density measurements in a multicenter trial: The postmenopausal estrogen/progestin interventions (PEPI) experience Wasilauskas, Carol H.
1991
12 5 p. 715-
1 p.
artikel
85 Development of a computerized network for registration and randomization in a large-scale multicenter clinical trial Santoro, E.
1991
12 5 p. 691-692
2 p.
artikel
86 Development of standardized software for analysis of clinical data Johnson, C.
1991
12 5 p. 719-
1 p.
artikel
87 Does central monitoring of the timeless of forms result in a decrease in the quality of data Koski, Beverly
1991
12 5 p. 708-
1 p.
artikel
88 Does participation on concurrent clinical trials compromise the quality of the data or its timely submission Palmer, Michael J.
1991
12 5 p. 713-714
2 p.
artikel
89 Drug supply system for the post CABG studies clinical trial Fox, Norma Lynn
1991
12 5 p. 649-
1 p.
artikel
90 Dynamical therapeutic strategies in clinical trials an example from the field of vascular surgery Schafer, Helmut
1991
12 5 p. 662-
1 p.
artikel
91 Dynamic balance randomization for clinical trials Leung, Oberon
1991
12 5 p. 669-
1 p.
artikel
92 Early patient accrual for a multicenter clinical trial Cauch, Karen
1991
12 5 p. 717-
1 p.
artikel
93 Electronic clinical trials in a group of UN community doctors Bourke, Alison
1991
12 5 p. 645-
1 p.
artikel
94 Electronic compliance monitoring in clinical trials: Benefits and risks Sahlroot, J.Todd
1991
12 5 p. 716-
1 p.
artikel
95 Electronic coordinating center—The centralized model Gross, Richard D.
1991
12 5 p. 674-
1 p.
artikel
96 Estimating effects of change in individual risk factors in a multifactorial intervention trial with group randomization Goetghebeur, Els
1991
12 5 p. 639-
1 p.
artikel
97 Estimating subgroup treatment effects in clinical trials Balley, Kent R.
1991
12 5 p. 626-627
2 p.
artikel
98 Ethical and legal considerations in clinical trials: An overview of the European diversity Duez, Nicole
1991
12 5 p. 712-
1 p.
artikel
99 Evaluating the impact of a change in review committee membership in a multicenter clinical trial Melia, Michele
1991
12 5 p. 636-
1 p.
artikel
100 Evaluation of prognostic factors from world wide clinical trials on prostata cancer Ringström, Jerker
1991
12 5 p. 699-
1 p.
artikel
101 Exact inference about the ratio of within-subject variances in a 2 x 2 crossover trial uner weak assumptions about the between-subject variability Gullbaud, Olivier
1991
12 5 p. 659-660
2 p.
artikel
102 Expanded coordinating center role: The postmenopausal estrogen/progestin interventions (PEPI) Trial Wells, H.Bradley
1991
12 5 p. 679-
1 p.
artikel
103 Extended Mantel-Haenszel procedures for analyzing multicenter clinical trials Davis, Charles S.
1991
12 5 p. 686-
1 p.
artikel
104 Facing unexpected major interaction—Results from a trial on graves' disease Fischer, Christine
1991
12 5 p. 636-
1 p.
artikel
105 Factors affecting the sample size benefits of run-in strategies Gordon, Mae E.
1991
12 5 p. 651-
1 p.
artikel
106 Follow-up of trials funded by NIH in 1979: Evidence of publication bias Dickersin, Kay
1991
12 5 p. 634-
1 p.
artikel
107 Getting more power from pair-wise comparisons in a three group design while protecting the experiment-wise error rate Thompson, Bruce
1991
12 5 p. 685-
1 p.
artikel
108 Global tests of efficacy for multiple end-points when not all endpoints apply to each study patient Alvir, Jose Ma.J.
1991
12 5 p. 684-
1 p.
artikel
109 Guidelines for monitoring company sponsored clinical trials in the pharmaceutical industry Banks, P.L.C.
1991
12 5 p. 715-716
2 p.
artikel
110 Guidelines for simultaneous participation in two or more randomized trials Simes, R.J.
1991
12 5 p. 661-662
2 p.
artikel
111 Heterogeneity in meta-analysis: Potential strategy of identification, analysis and practical interpretation Nony, P.
1991
12 5 p. 700-
1 p.
artikel
112 24-hour blood pressure measurement; methods of analysis and data requirements Dickson, Dorothy
1991
12 5 p. 665-666
2 p.
artikel
113 How many repeated estimates of response are needed for reliable assessment of efficacy in clinical trials? Szalai, John Paul
1991
12 5 p. 633-
1 p.
artikel
114 How one data coordinating center resolved its computing literacy problems Remaley, Nancy H.
1991
12 5 p. 663-
1 p.
artikel
115 How to show the equivalence of two vaccines in a clinical trial Albrecht, Neiss
1991
12 5 p. 643-
1 p.
artikel
116 Imperfectly observed chronic disease histories: A monte-carlo approach to inference applied to cervical cancer screening data Kirby, A.Jill
1991
12 5 p. 639-640
2 p.
artikel
117 Implementation of concentration-controlled trials (CCTs) Sanathanan, L.
1991
12 5 p. 655-
1 p.
artikel
118 Implementing the European community (EC) good clinical practice guidelines in Canada: A national cooperative group's report Paul, Nancy
1991
12 5 p. 682-683
2 p.
artikel
119 Improved monitoring of multicenter trials by an extended database Holle, Rolf
1991
12 5 p. 707-708
2 p.
artikel
120 Improvement of short term aids incidence predictions by relating the logistic functions used for curve fitting actual data with a deterministic model describing the aids epidemic de Haan, B.J.
1991
12 5 p. 689-690
2 p.
artikel
121 Improvements of data quality at clinical trials applying a scientific physician computer interface Werdler, Dieter
1991
12 5 p. 663-664
2 p.
artikel
122 Inter-data center and inter-group collaboration: The EORTC experience Thomas, Denis
1991
12 5 p. 629-
1 p.
artikel
123 Intergroup participation—The challenge of multigroup trials McFadden, Eleanor T.
1991
12 5 p. 674-675
2 p.
artikel
124 Interim monitoring for vaccine efficacy Reed, George F.
1991
12 5 p. 669-
1 p.
artikel
125 Interim p-values for group sequentially monitored trials Davis, Kathryn
1991
12 5 p. 668-
1 p.
artikel
126 Interpreting “negative” meta-analysis: True lack of efficacy, mixture of heterogeneous trials or a type II error problem? Leizorovicz, Alain
1991
12 5 p. 656-657
2 p.
artikel
127 Intraclass correlation coefficient—methodology and applications Müller, Reinhold
1991
12 5 p. 690-
1 p.
artikel
128 Investigation of aickins measure of agreement Kok, Frank G.
1991
12 5 p. 628-
1 p.
artikel
129 Issues in sample size determination when replicate measures are observed Rademaker, Alfred W.
1991
12 5 p. 642-
1 p.
artikel
130 Issues in the design and analysis of factorial design trials: The international TPA/SK mortality trial Simes, R.J.
1991
12 5 p. 652-
1 p.
artikel
131 Length of follow-up in randomized clinical trials Rockette, Howard E.
1991
12 5 p. 662-
1 p.
artikel
132 Linking the program for randomization to the production of preprinted color coded specimen labels Wasilauskas, Carol H.
1991
12 5 p. 691-
1 p.
artikel
133 Locating patients lost to follow-up in clinical trials Wiggins, Kerri
1991
12 5 p. 680-
1 p.
artikel
134 Low cost database management in clinical trials—Riding the tidal wave of technology Duncan, David
1991
12 5 p. 621-
1 p.
artikel
135 Management of data files in preparation for statistical analysis Raiz, Pauline
1991
12 5 p. 709-
1 p.
artikel
136 Management of study proposals: From an idea to a manuscript Forman, Sandra
1991
12 5 p. 682-
1 p.
artikel
137 Measuring screening biases in case fatality analyses with clinical trial data Chu, Kenneth
1991
12 5 p. 640-
1 p.
artikel
138 Meta-analyses of animal experiments Freedman, Lawrence S.
1991
12 5 p. 656-
1 p.
artikel
139 Methods of toxicity data collection: An evaluation of the relative effectiveness of the case report flow sheet (FS), the patient symptom diary (SD), and the quality of life questionnaire (QLQ) Paul, Nancy
1991
12 5 p. 648-
1 p.
artikel
140 Methods to estimate the distribution of the additional stay in hospital due to nosocomial infections Schulgen, Gabi
1991
12 5 p. 627-628
2 p.
artikel
141 Modelling morbidity of major diseases in a community from a delphi-type data Oranga, H.M.
1991
12 5 p. 640-
1 p.
artikel
142 Model selection procedures in analyzing case-control studies Blettner, Maria
1991
12 5 p. 641-
1 p.
artikel
143 Modifications to point summary odds ratio estimators Orozco, Jose Antonio
1991
12 5 p. 688-
1 p.
artikel
144 Monotone spline additive-risks model Abrahamowicz, Michal
1991
12 5 p. 619-
1 p.
artikel
145 Mortality probabilistic model for breast cancer screening: Survival effect of several screenings Daures, J.P.
1991
12 5 p. 718-719
2 p.
artikel
146 Multicenter trials: Analysis with treatment by center interactions Stammer, H.
1991
12 5 p. 627-
1 p.
artikel
147 Multivariate latent trait models for the analysis of repeated dichotomous measurements Zwinderman, Aellko H.
1991
12 5 p. 647-
1 p.
artikel
148 Nonparametric and parametric statistical safety screening of clinical trial laboratory data Nitzberg, David M.
1991
12 5 p. 701-
1 p.
artikel
149 Observed versus expected: Verifying clinical impressions in ophthalmologic trials Diener-West, Marie
1991
12 5 p. 696-
1 p.
artikel
150 Observer bias superimposed on observer variability: Results of a wine tasting Burdick, Elisabeth
1991
12 5 p. 713-
1 p.
artikel
151 On the design and analysis of randomized clinical trials with multiple end-points Geller, Nancy L.
1991
12 5 p. 665-
1 p.
artikel
152 Orientation and training for clinical research personnel: A 5 year perspective Gutknecht, G.D.
1991
12 5 p. 714-
1 p.
artikel
153 Outcome measures in a clinical trial to compare two methods of management of tibial fractures Raab, Gillian M.
1991
12 5 p. 623-
1 p.
artikel
154 Parallel randomized and nonrandomized clinical trials: What can we gain? Marcus, Sue M.
1991
12 5 p. 668-
1 p.
artikel
155 Patient response in a large follow-up by mail Mickel, Mary
1991
12 5 p. 680-
1 p.
artikel
156 Phase I trials: Is it better to use patients or normal volunteers? Kapit, Richard M.
1991
12 5 p. 658-659
2 p.
artikel
157 Planning, designing and implementing a prospective meta-analysis study Margitic, Susan E.
1991
12 5 p. 631-
1 p.
artikel
158 Post-stratification approach to missing data problems in clinical trials Lee, Young Jack
1991
12 5 p. 625-
1 p.
artikel
159 Predicting physician accrual of patients onto randomized clinical trials: Physician orientation profile Taylor, Kathryn M.
1991
12 5 p. 678-679
2 p.
artikel
160 Preplanned meta-analyses in a clinical trial aimed at reducing frailty and injuries in older persons Miller, J.P.
1991
12 5 p. 630-631
2 p.
artikel
161 Presentation of clinical data Altman, Douglas G.
1991
12 5 p. 720-721
2 p.
artikel
162 Primary prevention trials of cholesterol lowering agents: A tale of three trials Ford, Ian
1991
12 5 p. 697-
1 p.
artikel
163 Problems in estimating cost effectiveness in clinical trials: Experimental versus implementation costs DeNino, L.A.
1991
12 5 p. 633-634
2 p.
artikel
164 Problems of covariate adjustment in clinical trials Holle, Rolf
1991
12 5 p. 652-
1 p.
artikel
165 Process of obtaining NDI information to determine the vital status and cause of death of CASS registry patients Ng, Grace
1991
12 5 p. 707-
1 p.
artikel
166 Progress and problems in establishing an international registry of perinatal trials (IROPT) Chaimers, lain
1991
12 5 p. 630-
1 p.
artikel
167 Psychometric models concerning rating scales and inventories as end-point measures in behavioral intervention trials Frick, Ulrich
1991
12 5 p. 624-
1 p.
artikel
168 Publication practices in NIH-sponsored multicenter clinical trials Hawkins, Barbara S.
1991
12 5 p. 634-
1 p.
artikel
169 Quality control in the diabetes control and complications trial (DCCT) Owen, Walter
1991
12 5 p. 715-
1 p.
artikel
170 Quality of life assessment: Patient compliance with questionnaire completion Sadura, Anna
1991
12 5 p. 708-709
2 p.
artikel
171 Quality of life evaluation in clinical trials in cancer medicine Hoffman, J.
1991
12 5 p. 654-
1 p.
artikel
172 Qualtification of fluorescence properties of lymphocytes from properties of mixture populations of blood cells: A latent class approach van Putten, W.L.J.
1991
12 5 p. 647-
1 p.
artikel
173 Randomization by cluster: An example from the field of perinatal trials Elbourne, Diana
1991
12 5 p. 663-
1 p.
artikel
174 Randomized trials in psychosomatic medicine: Practical solutions to typical design problems Kieser, Meinhard
1991
12 5 p. 694-
1 p.
artikel
175 Recent developments in statistical methods for evaluating uniformity of treatment effects Simon, Richard
1991
12 5 p. 626-
1 p.
artikel
176 Recruitment experience in the full scale phase of the modification of diet in renal disease (MDRD) study Kusek, John W.
1991
12 5 p. 678-
1 p.
artikel
177 Recruitment in three different obstetric randomized controlled trials from a center coordinator's point of view Weston, Julie
1991
12 5 p. 677-
1 p.
artikel
178 Recruitment of patients into company sponsored clinical trials in Australia Cutler, Stephen A.
1991
12 5 p. 678-
1 p.
artikel
179 Recursive partition methods for the analysis of prognostic factors in advanced ovarian cancer Valsecchi, M.G.
1991
12 5 p. 687-
1 p.
artikel
180 Recursive structural model: An approach to analyze data with treatment adherence problem in randomized clinical trials Zee, Benny C.
1991
12 5 p. 625-626
2 p.
artikel
181 Redefining outcome in an ongoing trial: Convening a consensus panel Hawson, Sheila
1991
12 5 p. 711-712
2 p.
artikel
182 Reference values and analysis of routine clinical laboratory data in clinical trials Wilson, Michael G.
1991
12 5 p. 703-
1 p.
artikel
183 Relationship of P-value to conditional and predictive power in interim analysis VanRaden, Mark
1991
12 5 p. 642-
1 p.
artikel
184 Relationship of tumor response and survival in advanced ovarian cancer patients treated with chemotherapy Torri, Valter
1991
12 5 p. 705-
1 p.
artikel
185 Repeated measurements designs with a first order autoregressive pattern: Testing circularity and serial correlation Casana, Bruno
1991
12 5 p. 632-
1 p.
artikel
186 Reporting events in a large clinical trial: A flexible and dynamic database design Steenkiste, Ann R.
1991
12 5 p. 681-
1 p.
artikel
187 Reporting of toxicity data in prospective clinical trials: Current patterns of practice and implications for analysis Brundage, Michael
1991
12 5 p. 681-
1 p.
artikel
188 Results from clinical trials: How should they influence other ongoing clinical studies? Laupacis, Andreas
1991
12 5 p. 635-
1 p.
artikel
189 Risk groups of lung cancer and the model of the people screening Dinya, E.
1991
12 5 p. 673-
1 p.
artikel
190 Robust logistic regression in diagnosis assistance and clinical trials applications Krusinska, Ewa
1991
12 5 p. 689-
1 p.
artikel
191 Robust sequential crossover designs for clinical trials Filloon, Tom G.
1991
12 5 p. 694-
1 p.
artikel
192 Sample size and power for comparing vaccines Blackwelder, William C.
1991
12 5 p. 643-
1 p.
artikel
193 Sample size for sequentially monitored trials with noncompliance and lag Lakatos, Edward
1991
12 5 p. 638-
1 p.
artikel
194 Sample size issues for inferences about correlated proportions Elashoff, Janet D.
1991
12 5 p. 669-
1 p.
artikel
195 Sample sizes of prevention trials have been too small Ederer, Fred
1991
12 5 p. 650-651
2 p.
artikel
196 Sampling the universe for the bypass angioplasty revascularization investigation Detre, Katherine
1991
12 5 p. 650-
1 p.
artikel
197 Searching for hidden periodicities in biological time series Carr, David
1991
12 5 p. 710-
1 p.
artikel
198 Selecting a point estimator of blood pressure from consecutive measurements Gassman, Jennifer J.
1991
12 5 p. 709-710
2 p.
artikel
199 Serial correlation in the design and analysis of crossover trials Matthews, John N.S.
1991
12 5 p. 659-
1 p.
artikel
200 Shared quality control in a distributed data entry system Hogan, Patricia E.
1991
12 5 p. 646-
1 p.
artikel
201 Simulation in clinical trial design Yateman, Nigel A.
1991
12 5 p. 670-
1 p.
artikel
202 Simultaneous randomization to multiple dose levels and an active comparator as a means of determining the minimal effective dose of an investigational agent Pater, Joseph L.
1991
12 5 p. 696-
1 p.
artikel
203 Society for clinical trials: Board of directors, officers 1991–1992 1991
12 5 p. 588-589
2 p.
artikel
204 Sociodemographic characteristics associated with patient enrollment in the collaborative ocular melanoma study Diener-West, Marie
1991
12 5 p. 657-658
2 p.
artikel
205 So clean it squeaks—comparison of data collected by two independent groups on the same trial Palmer, Michael J.
1991
12 5 p. 693-
1 p.
artikel
206 Software for the management of large multicenter trials which involve several trials offices Bliss, Judith
1991
12 5 p. 675-
1 p.
artikel
207 Software solutions for management of clinical data—Present and future Michael, Martin
1991
12 5 p. 664-
1 p.
artikel
208 Some useful distribution-free multivariate estimators and tests for the analysis of repeated measures in a clinical trial Lachin, John M.
1991
12 5 p. 631-
1 p.
artikel
209 Sources of variation in clinical center workloads during a 15-year period Keller, Jean A.
1991
12 5 p. 712-
1 p.
artikel
210 Spectral analysis of the effect of drug treatment on the circadian pattern of blood pressure and angina Gaffney, Michael
1991
12 5 p. 666-
1 p.
artikel
211 Stability of meta-analysis (M-As) of randomized control trials (RCTs): A retrospective study of 10 published M-As by sequential M-As and the implications for prospective M-As Lau, J.
1991
12 5 p. 705-
1 p.
artikel
212 Statistical analysis of multiple failures in clinical trials for treatment of drug dependence Jain, Ram B.
1991
12 5 p. 664-
1 p.
artikel
213 Statistical aspects in the analysis of a breast cancer clinical trial Schmoor, Claudia
1991
12 5 p. 700-
1 p.
artikel
214 Statistical controversies in meta-analysis: Fixed effects or random effects models? Thompson, S.G.
1991
12 5 p. 626-
1 p.
artikel
215 Statistical issues addressed in a large screening trial Wleand, S.
1991
12 5 p. 660-
1 p.
artikel
216 Statistical methods for analyzing heart rate irregularity during atrial fibrillation Jonsson, Robert
1991
12 5 p. 646-
1 p.
artikel
217 Statistical models for correlated responses in graft patency assessment Marubini, E.
1991
12 5 p. 660-
1 p.
artikel
218 Statistical models to evaluate the impact of cancer clinical trial advances on population survival Feuer, Eric J.
1991
12 5 p. 618-
1 p.
artikel
219 Stochastic curtailment—or when should we stop or continue a clinical trial? Ulm, Kurt
1991
12 5 p. 637-
1 p.
artikel
220 Subgroup analyses in clinical trials McMahon, Robert
1991
12 5 p. 686-687
2 p.
artikel
221 Subsampling strategies in clinical trials Davis, Vicki G.
1991
12 5 p. 652-653
2 p.
artikel
222 Surfactant replacement therapy for severe neonatal respiratory distress syndrome: Biometrical aspects and results of the European multicenter randomized clinical trial Gefeller, Olaf
1991
12 5 p. 697-698
2 p.
artikel
223 Surveillance in medicine Frisen, Marianne
1991
12 5 p. 672-
1 p.
artikel
224 Survival in cardiac insufficiency after captopril treatment: Midterm analysis Assennato, G.
1991
12 5 p. 699-
1 p.
artikel
225 Suspended judgment the optimistic bias favoring medical action Silverman, William A.
1991
12 5 p. 557-559
3 p.
artikel
226 Teaching probabilistic expert system using clinical data Spiegelhalter, David J.
1991
12 5 p. 640-641
2 p.
artikel
227 Telecommunications: A tool for information dissemination in multicenter clinical trials Crow, Sharon
1991
12 5 p. 675-
1 p.
artikel
228 Telecommunication techniques in a distributed data entry system for multicenter clinical trials Kamors, Larry
1991
12 5 p. 676-
1 p.
artikel
229 The analysis of multiple end points with a two-stage group sequential design Legault, Claudine
1991
12 5 p. 667-
1 p.
artikel
230 The benefits of producing data collection forms the hard way Singer, Stephen W.
1991
12 5 p. 648-
1 p.
artikel
231 The Canadian abdominal aortic aneurysm (AAA) treatment trial Moher, David
1991
12 5 p. 698-
1 p.
artikel
232 The changing role of a project manager during a multicenter clinical trial Margitic, Susan E.
1991
12 5 p. 629-
1 p.
artikel
233 The choice of sequential boundaries based on the concept of power spending Bauer, Peter
1991
12 5 p. 637-
1 p.
artikel
234 The cost effectiveness of a run-in strategy in a randomized clinical trial Schechtman, Kenneth B.
1991
12 5 p. 633-
1 p.
artikel
235 The development of PC-based distributed data entry system for the P2C2HIV study McPherson, Joseph A.
1991
12 5 p. 676-
1 p.
artikel
236 The effect of supervised brushing on evaluating the efficacy of a caries clinical trial Moorhead, Jacquelyn
1991
12 5 p. 713-
1 p.
artikel
237 The implementation of a voice information system in clinical trials Chow, Bruce
1991
12 5 p. 676-
1 p.
artikel
238 The importance of counting all the patients Terrin, Michael
1991
12 5 p. 686-
1 p.
artikel
239 The influence of missing data in the analysis of composite endpoints Thompson, Bruce
1991
12 5 p. 685-
1 p.
artikel
240 The modification of diet in renal disease study group Beck, Gerald J.
1991
12 5 p. 566-586
21 p.
artikel
241 The need for multivariate analysis: A survey of uterine sarcoma in the west Midlands health region Dunn, J.A.
1991
12 5 p. 687-688
2 p.
artikel
242 The perinatal trials service Grant, Adrian
1991
12 5 p. 679-
1 p.
artikel
243 The questions we have to answer when using QALYS Noack, Herbert
1991
12 5 p. 711-
1 p.
artikel
244 Therapeutic coverage: A crossover comparison between two drugs of the same class in outpatient practice Heynen, Guy
1991
12 5 p. 668-
1 p.
artikel
245 Therapeutic coverage: A parameter for analyzing the pharmacodynamic impact of partial patient compliance Urquhart, John
1991
12 5 p. 672-
1 p.
artikel
246 The relative importance of prognostic factors in studies of survival Schemper, Michael
1991
12 5 p. 639-
1 p.
artikel
247 The role of comorbidity on the feasibility and outcome of quality of care and effectiveness studies Apolone, G.
1991
12 5 p. 651-
1 p.
artikel
248 The role of quality of life assessments in clinical trials Fayers, Peter
1991
12 5 p. 653-
1 p.
artikel
249 The tridimensional personality questionnaire as a predictor of outcome in a randomized trial of nefazodone, imipramine and placebo in depression Schwiderski, Ute
1991
12 5 p. 701-
1 p.
artikel
250 The use of the propensity score in the analysis of clinical trials Abramowski, Erika
1991
12 5 p. 666-
1 p.
artikel
251 Thirteenth annual meeting of the Society for clinical trials May 10–13, 1992 Adam's Mark Hotel Philadelphia, Pennsylvania 1991
12 5 p. 587-
1 p.
artikel
252 Too many trials with too small sample sizes Messerer, Dorle
1991
12 5 p. 650-
1 p.
artikel
253 Towards a standardization of DDE Bailey, Lance R.
1991
12 5 p. 644-
1 p.
artikel
254 Towards more “informed” consent in clinical trials: An information booklet for patients and physicians in the UK Easterbrook, Philippa
1991
12 5 p. 657-
1 p.
artikel
255 Towards reducing observer effects in blood pressure (BP) measurement Hogan, Patricia E.
1991
12 5 p. 709-
1 p.
artikel
256 Twelfth annual meeting of the society for clinical trials international society for clinical biostatistics 1991
12 5 p. 590-617
28 p.
artikel
257 Two-step procedure for survival analysis Bartolucci, Alfred A.
1991
12 5 p. 704-
1 p.
artikel
258 Usefulness of collecting individual data in meta-analyses Pignon, Jean-Pierre
1991
12 5 p. 630-
1 p.
artikel
259 Use of an artificial neural network for statistical pattern recognition Clarke, Ellis
1991
12 5 p. 641-
1 p.
artikel
260 Use of computer applications to facilitate retroactive updates to a database Pelusio, Rita M.
1991
12 5 p. 707-
1 p.
artikel
261 Use of interim analyses to design further studies in drug programs Lipschutz, Katherine
1991
12 5 p. 683-
1 p.
artikel
262 Use of relational database “views” in clinical trial data management LoPresti, Frances
1991
12 5 p. 620-621
2 p.
artikel
263 Using the accrual period to update sample size estimates in prevention studies Thornquist, Mark D.
1991
12 5 p. 641-642
2 p.
artikel
264 Using the foxpro code generator in the development of a distributed data entry system McPherson, Joseph A.
1991
12 5 p. 645-646
2 p.
artikel
265 Validity of the bootstrap for a Hodges-Lehmann type estimator in the two-sample problem with censoring Bassiakos, Ylannis
1991
12 5 p. 702-
1 p.
artikel
266 Variability of CD4 counts, a surrogate marker for disease progression in HIV-infected individuals Aber, Victor
1991
12 5 p. 623-
1 p.
artikel
267 Visualization of clinical data with the SAS(R) system Held, Gerhard
1991
12 5 p. 665-
1 p.
artikel
268 Visualizing the effect of time-dependent covariates using the Cox model: A simple method and application Thompson, Bruce
1991
12 5 p. 618-619
2 p.
artikel
269 When to stop an ongoing trial: The case of adjuvant chemotherapy on colon cancer (ACCC) Marsoni, S.
1991
12 5 p. 635-
1 p.
artikel
                             269 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland